Bio-Techne Corporation (TECH): A Bull Case Theory
A close-up of a biotechnology machine working on an oncology therapy.
Bio-Techne has built a diverse and complex business centered on its strong legacy in recombinant proteins, expanding downstream into antibodies, assays, and instrument platforms, while also moving into cell and gene therapy (CGT) solutions. Its revenue is split roughly between Protein Sciences and Diagnostics, which are closely linked—diagnostics identify disease biomarkers that then become therapeutic targets developed using Bio-Techne's proteins and antibodies. Despite about 20 acquisitions over the past decade, its core legacy products still contribute 56% of total revenue, with the remainder coming from faster-growing, less penetrated markets.
Around half of Bio-Techne's revenue comes from commercial R&D, now dominated by smaller, venture-funded biotechs rather than big pharma, making this segment more cyclical. Academia accounts for another 20%, a price-sensitive group vulnerable to budget swings. The company is gaining ground in GMP protein production for clinical and commercial use, a highly regulated and lucrative niche, though it trails established leaders like Miltenyi and Cellgenix. Bio-Techne has also expanded into proteomics and spatial biology through acquisitions.
While the company once forecasted nearly $2 billion in revenue by 2026, growth slowed due to several factors: COVID-related demand spikes followed by inventory destocking, a 20-30% revenue decline in China, fading COVID testing tailwinds, and cautious FDA oversight of CGTs that hurt growth expectations. Despite these setbacks causing a nearly 50% stock price decline, recent signs point to recovery with organic growth rebounding to 9% and instrument sales improving. Bio-Techne's broad strategy reflects its efforts to protect core franchises while expanding into new growth areas, including becoming an instrument provider to capture more downstream value.
Bio-Techne Corporation (TECH) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 34 hedge fund portfolios held TECH at the end of the first quarter which was 24 in the previous quarter. While we acknowledge the risk and potential of TECH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than TECH but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.
Disclosure: None. This article was originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Epoch Times
13 minutes ago
- Epoch Times
American Academy of Pediatrics Recommends COVID-19 Vaccine for All Infants
The American Academy of Pediatrics (AAP) on Aug. 19 recommended that many young children receive a COVID-19 vaccine, diverging from the Centers for Disease Control and Prevention's immunization schedule. All children ages 6 to 23 months should receive a COVID-19 vaccine, regardless of prior infection or vaccination, the AAP said in its updated schedule, unless they have a contraindication such as a history of severe allergic reaction to a vaccine ingredient.
NBC News
an hour ago
- NBC News
Immigration crackdown, tariffs blamed by some for tourist slowdown in Las Vegas
LAS VEGAS — Tourism in Las Vegas is slumping this summer, with resorts and convention centers reporting fewer visitors compared to last year, especially from abroad, and some officials are blaming the Trump administration's tariffs and immigration policies for the decline. The city known for lavish shows, endless buffets and around-the-clock gambling welcomed just under 3.1 million tourists in June, an 11% drop compared to the same time in 2024. There were 13% fewer international travelers, and hotel occupancy fell by about 15%, according to data from the Las Vegas Convention and Visitors Authority. Mayor Shelley Berkley said tourism from Canada — Nevada's largest international market — has dried up from a torrent "to a drip." Same with Mexico. "We have a number of very high rollers that come in from Mexico that aren't so keen on coming in right now. And that seems to be the prevailing attitude internationally," Berkley told reporters earlier this month. Ted Pappageorge, head of the powerful Culinary Workers Union, called it the "Trump slump." He said visits from Southern California, home to a large Latino population, were also drying up because people are afraid of the administration's immigration crackdown. "If you if you tell the rest of the world they're not welcome, then they won't come," Pappageorge said. Canadian airline data shows fewer passengers from north of the border are arriving at Harry Reid International Airport in Las Vegas. Air Canada saw its passenger numbers fall by 33% in June compared to the same time a year ago, while WestJet had a 31% drop. The low-cost carrier Flair reported a whopping 62% decline. Travel agents in Canada said there's been a significant downturn in clients wanting to visit the U.S. overall, and Las Vegas in particular. Wendy Hart, who books trips from Windsor, Ontario, said the reason was "politics, for sure." She speculated that it was a point of "national pride" that people were staying away from the U.S. after President Donald Trump said he wanted to make Canada the 51st state. "The tariffs are a big thing too. They seem to be contributing to the rising cost of everything," Hart said. At downtown's Circa Resort and Casino, international visits have dipped, especially from Canada and Japan, according to owner and CEO Derek Stevens. But the downturn comes after a post-COVID spike, Stevens said. And while hotel room bookings are slack, gaming numbers, especially for sports betting, are still strong, he said. "It's not as if the sky is falling," he said. Wealthier visitors are still coming, he said, and Circa has introduced cheaper package deals to lure those with less money to spend. "There have been many stories written about how the 'end is near' in Vegas," he said. "But Vegas continues to reinvent itself as a destination worth visiting." On AAA's annual top ten list of top Labor Day destinations, Las Vegas slipped this year to the last spot, from number six in 2024. Seattle and Orlando, Florida — home to Disneyworld — hold steady in the top two spots, with New York City moving up to third for 2025. Reports of declining tourism were news to Alison Ferry, who arrived from Donegal, Ireland, to find big crowds at casinos and the Vegas Strip. "It's very busy. It has been busy everywhere that we've gone. And really, really hot," Ferry said. She added that she doesn't pay much attention to U.S. politics. Just off the strip, there's been no slowdown at the Pinball Museum, which showcases games from the 1930s through today. Manager Jim Arnold said the two-decade-old attraction is recession-proof because it's one of the few places to offer free parking and free admission. "We've decided that our plan is just to ignore inflation and pretend it doesn't exist," Arnold said. "So you still take a quarter out of your pocket and put it in a game, and you don't pay a resort fee or a cancelation fee or any of that jazz." But Arnold said he's not surprised that overall tourism might be slowing because of skyrocketing prices at high-end restaurants and resorts, which "squeezes out the low end tourist." The mayor said the rising cost of food, hotel rooms and attractions also keeps visitors away. "People are feeling that they're getting nickeled and dimed, and they're not getting value for their dollar," Berkley said. She called on business owners to "see if we can't make it more affordable" for tourists. "And that's all we want. We want them to come and have good time, spend their money, go home," the mayor said. "Then come back in six months."
Bloomberg
an hour ago
- Bloomberg
Pediatric Group Breaks With CDC to Recommend Kids' Covid Shots
The American Academy of Pediatrics updated its recommendations for immunizations Tuesday, including Covid shots for healthy kids, differing from advice from the federal government. The group said it recommends the Covid shot for children ages 6 to 23 months. Earlier this year, Health and Human Services Secretary Robert F. Kennedy Jr. changed course, saying healthy kids and pregnant women should not receive the vaccine.
